{
    "Trade/Device Name(s)": [
        "Wondfo Phencyclidine Urine Test",
        "Wondfo Notriptyline Urine Test",
        "Phencyclidine Urine Test",
        "Notriptyline Urine Test"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K112395",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020771",
        "K021526"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCM",
        "LFG"
    ],
    "Summary Letter Date": "August 15, 2011",
    "Summary Letter Received Date": "August 19, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3910"
    ],
    "Regulation Name(s)": [
        "Tricyclic antidepressant drug test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Phencyclidine",
        "Notriptyline"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup",
        "Dip card"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Competitive binding",
        "Lateral flow"
    ],
    "Methodologies": [
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo Phencyclidine and Notriptyline Urine Test qualitative lateral flow immunoassays for drug detection in urine",
    "Indications for Use Summary": "Qualitative determination of Phencyclidine and Notriptyline in human urine at specified cutoff concentrations using immunochromatographic assay for prescription and over-the-counter use",
    "fda_folder": "Toxicology"
}